These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1512 related items for PubMed ID: 17437796

  • 1. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML.
    J Urol; 2007 May; 177(5):1721-6. PubMed ID: 17437796
    [Abstract] [Full Text] [Related]

  • 2. Imperative indications for conservative management of upper tract transitional cell carcinoma.
    Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML.
    J Urol; 2007 Sep; 178(3 Pt 1):792-6; discussion 796-7. PubMed ID: 17632132
    [Abstract] [Full Text] [Related]

  • 3. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML, Stewart GD, Tudor EC, Egong EA, Wells-Cole S, Phipps S, Thomas BG, Riddick AC, McNeill SA, Tolley DA.
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [Abstract] [Full Text] [Related]

  • 4. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP.
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [Abstract] [Full Text] [Related]

  • 5. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
    Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML.
    BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Li CC, Chang TH, Wu WJ, Ke HL, Huang SP, Tsai PC, Chang SJ, Shen JT, Chou YH, Huang CH.
    Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
    [Abstract] [Full Text] [Related]

  • 10. Comparative outcomes following endoscopic ureteral detachment and formal bladder cuff excision in open nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Walton TJ, Sherwood BT, Parkinson RJ, Obakponovwe O, Thomas SA, Taylor MC, England RC, Lemberger RJ.
    J Urol; 2009 Feb; 181(2):532-9. PubMed ID: 19084866
    [Abstract] [Full Text] [Related]

  • 11. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 12. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
    Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O.
    Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H.
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [Abstract] [Full Text] [Related]

  • 17. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
    Volkmer BG, Schnoeller T, Kuefer R, Gust K, Finter F, Hautmann RE.
    J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T, Miyake H, Muramaki M, Takenaka A, Hara I, Fujisawa M.
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.